Q2 2022 13F Holders as of 6/30/2022
-
Type / Class
-
Equity / COM
-
Number of holders
-
9
-
Total 13F shares, excl. options
-
643K
-
Shares change
-
+15K
-
Total reported value, excl. options
-
$7.2M
-
Value change
-
+$372K
-
Number of buys
-
6
-
Number of sells
-
-5
-
Price
-
$11.20
Significant Holders of Nuvectis Pharma, Inc. - COM (NVCT) as of Q2 2022
11 filings reported holding NVCT - Nuvectis Pharma, Inc. - COM as of Q2 2022.
Nuvectis Pharma, Inc. - COM (NVCT) has 9 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 643K shares
.
Largest 10 shareholders include Ronit Capital LLP (419K shares), BALDWIN BROTHERS LLC/MA (121K shares), CITADEL ADVISORS LLC (35.1K shares), GEODE CAPITAL MANAGEMENT, LLC (24K shares), VANGUARD GROUP INC (23.3K shares), STATE STREET CORP (11.7K shares), BlackRock Inc. (7.2K shares), Tower Research Capital LLC (TRC) (1.28K shares), MORGAN STANLEY (200 shares), and Virtu Financial LLC (0 shares).
This table shows the top 9 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.